WokeMan123 personal page - To The Moon

WokeMan123

WokeMan123

No personal profile

23Follow

0Followers

0Topic

0Badge

2021-04-26

Comment please

Sorry, the original content has been removed

2021-05-05

Hihihihi like and comment please

IPO Preview: Honest Company, Chinese Lifestyle Brand Onion Global, Hydroponic iPower Lead Group

2021-05-02

Hi like and comment please

Sorry, the original content has been removed

2021-04-26

Hi like and comment please

Sorry, the original content has been removed

2021-05-01

Hi everyone like and comment please!

1 Question Tesla Investors Need to Ask Themselves

2021-05-04

Help comment and like please

After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading

2021-04-26

Lets all watch ocgn!! EUA

Sorry, the original content has been removed

2021-05-04

Hihi

After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading

2021-04-26

Hi

The psychology of a stock market bubble

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3580604694268529","uuid":"3580604694268529","gmtCreate":1617512489890,"gmtModify":1704806850038,"name":"WokeMan123","pinyin":"wokeman123","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","hatId":"shopping-5c7909103804749e0b21df6dfddc9bae","hatName":"2024 New Year frame","vip":1,"status":2,"fanSize":0,"headSize":23,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.18","exceedPercentage":"80.78%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.19","exceedPercentage":"93.71%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":106717072,"gmtCreate":1620145388796,"gmtModify":1704339354625,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580604694268529","authorIdStr":"3580604694268529"},"themes":[],"htmlText":"&nbsp;Hihihihi like and comment please","listText":"&nbsp;Hihihihi like and comment please","text":"Hihihihi like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/106717072","repostId":"1191168108","repostType":4,"repost":{"id":"1191168108","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1620139872,"share":"https://ttm.financial/m/news/1191168108?lang=en_US&edition=fundamental","pubTime":"2021-05-04 22:51","market":"us","language":"en","title":"IPO Preview: Honest Company, Chinese Lifestyle Brand Onion Global, Hydroponic iPower Lead Group","url":"https://stock-news.laohu8.com/highlight/detail?id=1191168108","media":"Benzinga","summary":"The week of May 3 has several IPOs on the docket spread across sectors like consumer products, fashi","content":"<p>The week of May 3 has several IPOs on the docket spread across sectors like consumer products, fashion, banking, vaccines and hydroponics. Here is a look at this week’s top offerings and details investors should know.</p>\n<p><b>Waterdrop:</b>Working with insurance companies,<b>Waterdrop</b>NYSEWDHseeksto have a positive social impact with its technology platform. Waterdrop has over 79.4 million cumulative customers and over 340 million donors to its crowdfunding platform, which is the largest medical crowdfunding platform in China.</p>\n<p>Waterdrop works with 62 insurance carriers and offers over 200 products to help customers and those seeking help with medical bills. The company had revenue of $464.1 million in fiscal 2020. The company plans on offering 30 million American depositary shares at a price point of $10 to $12.</p>\n<p><b>Five Star Bancorp:</b>With branches in California,<b>Five Star Bancorp</b>NASDAQFSBCisa regional bank company focused on the Sacramento market. The company ended 2020 with $1.8 billion in deposits and $1.5 billion in loans.</p>\n<p>From 2016 to 2020, the company saw compounded annual growth of 23.5% for assets, 23.8% for loans and 23.7% for deposits. First quarter preliminary numbers saw deposits grow 11.2% from the fourth quarter and loans grow 2.6% from the fourth quarter. The company plans on selling 5.265 million shares at a price point of $18 to $20.</p>\n<p><b>The Honest Company:</b>Clean lifestyle product company<b>The Honest Company</b>NASDAQHNSTcouldbe the most-watched IPO this week. The company was founded by actress Jessica Alba in 2012 in response to finding clean products and non-allergic reactions from products after giving birth.</p>\n<p>The Honest Company prides itself in being “a conscious living company for today and tomorrow.” The company has grown from being a diapers-and-wipes company to covering every age and every life stage of its customers.</p>\n<p>The Honest Company had revenue of $235.6 million in fiscal 2020, up 27.6% year-over-year. Diapers and wipes made up 63% of 2020 revenue, up 16.4% year-over-year. Skin and personal care product revenue represented 26% of sales in 2020 and were up 55% year-over-year. Household and wellness sales made up 11% of sales and had year-over-year growth of 116.5% in 2020. The Honest Company products can be purchased online from the company or sites like<b>Amazon.com</b>AMZN 1.77%and in physical stores like<b>Costco Wholesale Corporation</b>COST 0.54%and<b>Target Corporation</b>TGT 0.23%.</p>\n<p>Founder Alba will not sell any shares in the IPO and will own an estimated 6.1% of the company after the offering. The company isseekingto sell 25.8 million shares at a price point of $14 to $17.</p>\n<p><b>Bowman Consulting Group:</b>Professional services company<b>Bowman Consulting Group</b>NASDAQBWMNoffersengineering solutions to customers. Bowman Consulting has over 2,200 customers who count on the company for services like planning, engineering, construction management, commissioning, geomatics, survey, land procurement and environmental consulting. The company had revenue of $122 million in the last fiscal year, up from $113.7 million in the prior year. Bowman Consulting plans to offer 3.1 million shares at a price point of $12 to $14.</p>\n<p><b>Valneva:</b>Vaccine company<b>Valneva</b>NASDAQVLAplansto sell 7.1 million ordinary shares (3.55 million ADSs) at a price of $28.24. The company is focused on vaccine development in infectious diseases. Target areas include Lyme disease, the Chikungunya virus and COVID-19. The company’s lead program VLA15 is in Phase 2 trials to treat Lyme disease and is partnered with<b>Pfizer Corporation</b>PFE 0.49%. Other clinical trials include VLA1553 to treat Chikungunya virus and VLA2001 to treat COVID-19. The company’s VLA1553 is the only known Phase 3 trial vaccine to treat Chikungunya, which could put it in the spotlight with spread to over 100 countries. Several of the company’s products have received Fast Track designation by the FDA.</p>\n<p><b>Onion Global:</b>Lifestyle brand company<b>Onion Global</b>NYSEOGplanson selling 12.5 million ADS at a price point of $7.25 to $9.25. The company targets fresh, fashionable and future brands, which it refers to as the 3Fs across China and parts of Asia. The company has over 4,000 brands in 23 categories sold in 43 countries. Onion Global is a top ten global lifestyle company in China. The company uses an omnichannel approach with its self operated ecommerce platform O’Mall, live streaming sales, third party sellers and offline sales. The company has 2.1 million active buyers and 15.5 million registered users.</p>\n<p><b>iPower:</b>Online hydroponic equipment seller<b>iPower Inc</b>NASDAQIPWplansto offer 5&nbsp;million shares at a price point of $9 to $11. The company offers its own brands and partnered brands through its websitewww.zenhydro.com. iPower-owned brands represented 76% of company sales in the six month period ending December 31, 2020. The company had sales of $26.2 million in the six month period ending December 31, 2020. Preliminary first-quarter revenue is expected to be in a range of $11.75 million to $12.75 million compared to $9.4 million in the prior year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO Preview: Honest Company, Chinese Lifestyle Brand Onion Global, Hydroponic iPower Lead Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO Preview: Honest Company, Chinese Lifestyle Brand Onion Global, Hydroponic iPower Lead Group\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-05-04 22:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The week of May 3 has several IPOs on the docket spread across sectors like consumer products, fashion, banking, vaccines and hydroponics. Here is a look at this week’s top offerings and details investors should know.</p>\n<p><b>Waterdrop:</b>Working with insurance companies,<b>Waterdrop</b>NYSEWDHseeksto have a positive social impact with its technology platform. Waterdrop has over 79.4 million cumulative customers and over 340 million donors to its crowdfunding platform, which is the largest medical crowdfunding platform in China.</p>\n<p>Waterdrop works with 62 insurance carriers and offers over 200 products to help customers and those seeking help with medical bills. The company had revenue of $464.1 million in fiscal 2020. The company plans on offering 30 million American depositary shares at a price point of $10 to $12.</p>\n<p><b>Five Star Bancorp:</b>With branches in California,<b>Five Star Bancorp</b>NASDAQFSBCisa regional bank company focused on the Sacramento market. The company ended 2020 with $1.8 billion in deposits and $1.5 billion in loans.</p>\n<p>From 2016 to 2020, the company saw compounded annual growth of 23.5% for assets, 23.8% for loans and 23.7% for deposits. First quarter preliminary numbers saw deposits grow 11.2% from the fourth quarter and loans grow 2.6% from the fourth quarter. The company plans on selling 5.265 million shares at a price point of $18 to $20.</p>\n<p><b>The Honest Company:</b>Clean lifestyle product company<b>The Honest Company</b>NASDAQHNSTcouldbe the most-watched IPO this week. The company was founded by actress Jessica Alba in 2012 in response to finding clean products and non-allergic reactions from products after giving birth.</p>\n<p>The Honest Company prides itself in being “a conscious living company for today and tomorrow.” The company has grown from being a diapers-and-wipes company to covering every age and every life stage of its customers.</p>\n<p>The Honest Company had revenue of $235.6 million in fiscal 2020, up 27.6% year-over-year. Diapers and wipes made up 63% of 2020 revenue, up 16.4% year-over-year. Skin and personal care product revenue represented 26% of sales in 2020 and were up 55% year-over-year. Household and wellness sales made up 11% of sales and had year-over-year growth of 116.5% in 2020. The Honest Company products can be purchased online from the company or sites like<b>Amazon.com</b>AMZN 1.77%and in physical stores like<b>Costco Wholesale Corporation</b>COST 0.54%and<b>Target Corporation</b>TGT 0.23%.</p>\n<p>Founder Alba will not sell any shares in the IPO and will own an estimated 6.1% of the company after the offering. The company isseekingto sell 25.8 million shares at a price point of $14 to $17.</p>\n<p><b>Bowman Consulting Group:</b>Professional services company<b>Bowman Consulting Group</b>NASDAQBWMNoffersengineering solutions to customers. Bowman Consulting has over 2,200 customers who count on the company for services like planning, engineering, construction management, commissioning, geomatics, survey, land procurement and environmental consulting. The company had revenue of $122 million in the last fiscal year, up from $113.7 million in the prior year. Bowman Consulting plans to offer 3.1 million shares at a price point of $12 to $14.</p>\n<p><b>Valneva:</b>Vaccine company<b>Valneva</b>NASDAQVLAplansto sell 7.1 million ordinary shares (3.55 million ADSs) at a price of $28.24. The company is focused on vaccine development in infectious diseases. Target areas include Lyme disease, the Chikungunya virus and COVID-19. The company’s lead program VLA15 is in Phase 2 trials to treat Lyme disease and is partnered with<b>Pfizer Corporation</b>PFE 0.49%. Other clinical trials include VLA1553 to treat Chikungunya virus and VLA2001 to treat COVID-19. The company’s VLA1553 is the only known Phase 3 trial vaccine to treat Chikungunya, which could put it in the spotlight with spread to over 100 countries. Several of the company’s products have received Fast Track designation by the FDA.</p>\n<p><b>Onion Global:</b>Lifestyle brand company<b>Onion Global</b>NYSEOGplanson selling 12.5 million ADS at a price point of $7.25 to $9.25. The company targets fresh, fashionable and future brands, which it refers to as the 3Fs across China and parts of Asia. The company has over 4,000 brands in 23 categories sold in 43 countries. Onion Global is a top ten global lifestyle company in China. The company uses an omnichannel approach with its self operated ecommerce platform O’Mall, live streaming sales, third party sellers and offline sales. The company has 2.1 million active buyers and 15.5 million registered users.</p>\n<p><b>iPower:</b>Online hydroponic equipment seller<b>iPower Inc</b>NASDAQIPWplansto offer 5&nbsp;million shares at a price point of $9 to $11. The company offers its own brands and partnered brands through its websitewww.zenhydro.com. iPower-owned brands represented 76% of company sales in the six month period ending December 31, 2020. The company had sales of $26.2 million in the six month period ending December 31, 2020. Preliminary first-quarter revenue is expected to be in a range of $11.75 million to $12.75 million compared to $9.4 million in the prior year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IPW":"iPower Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191168108","content_text":"The week of May 3 has several IPOs on the docket spread across sectors like consumer products, fashion, banking, vaccines and hydroponics. Here is a look at this week’s top offerings and details investors should know.\nWaterdrop:Working with insurance companies,WaterdropNYSEWDHseeksto have a positive social impact with its technology platform. Waterdrop has over 79.4 million cumulative customers and over 340 million donors to its crowdfunding platform, which is the largest medical crowdfunding platform in China.\nWaterdrop works with 62 insurance carriers and offers over 200 products to help customers and those seeking help with medical bills. The company had revenue of $464.1 million in fiscal 2020. The company plans on offering 30 million American depositary shares at a price point of $10 to $12.\nFive Star Bancorp:With branches in California,Five Star BancorpNASDAQFSBCisa regional bank company focused on the Sacramento market. The company ended 2020 with $1.8 billion in deposits and $1.5 billion in loans.\nFrom 2016 to 2020, the company saw compounded annual growth of 23.5% for assets, 23.8% for loans and 23.7% for deposits. First quarter preliminary numbers saw deposits grow 11.2% from the fourth quarter and loans grow 2.6% from the fourth quarter. The company plans on selling 5.265 million shares at a price point of $18 to $20.\nThe Honest Company:Clean lifestyle product companyThe Honest CompanyNASDAQHNSTcouldbe the most-watched IPO this week. The company was founded by actress Jessica Alba in 2012 in response to finding clean products and non-allergic reactions from products after giving birth.\nThe Honest Company prides itself in being “a conscious living company for today and tomorrow.” The company has grown from being a diapers-and-wipes company to covering every age and every life stage of its customers.\nThe Honest Company had revenue of $235.6 million in fiscal 2020, up 27.6% year-over-year. Diapers and wipes made up 63% of 2020 revenue, up 16.4% year-over-year. Skin and personal care product revenue represented 26% of sales in 2020 and were up 55% year-over-year. Household and wellness sales made up 11% of sales and had year-over-year growth of 116.5% in 2020. The Honest Company products can be purchased online from the company or sites likeAmazon.comAMZN 1.77%and in physical stores likeCostco Wholesale CorporationCOST 0.54%andTarget CorporationTGT 0.23%.\nFounder Alba will not sell any shares in the IPO and will own an estimated 6.1% of the company after the offering. The company isseekingto sell 25.8 million shares at a price point of $14 to $17.\nBowman Consulting Group:Professional services companyBowman Consulting GroupNASDAQBWMNoffersengineering solutions to customers. Bowman Consulting has over 2,200 customers who count on the company for services like planning, engineering, construction management, commissioning, geomatics, survey, land procurement and environmental consulting. The company had revenue of $122 million in the last fiscal year, up from $113.7 million in the prior year. Bowman Consulting plans to offer 3.1 million shares at a price point of $12 to $14.\nValneva:Vaccine companyValnevaNASDAQVLAplansto sell 7.1 million ordinary shares (3.55 million ADSs) at a price of $28.24. The company is focused on vaccine development in infectious diseases. Target areas include Lyme disease, the Chikungunya virus and COVID-19. The company’s lead program VLA15 is in Phase 2 trials to treat Lyme disease and is partnered withPfizer CorporationPFE 0.49%. Other clinical trials include VLA1553 to treat Chikungunya virus and VLA2001 to treat COVID-19. The company’s VLA1553 is the only known Phase 3 trial vaccine to treat Chikungunya, which could put it in the spotlight with spread to over 100 countries. Several of the company’s products have received Fast Track designation by the FDA.\nOnion Global:Lifestyle brand companyOnion GlobalNYSEOGplanson selling 12.5 million ADS at a price point of $7.25 to $9.25. The company targets fresh, fashionable and future brands, which it refers to as the 3Fs across China and parts of Asia. The company has over 4,000 brands in 23 categories sold in 43 countries. Onion Global is a top ten global lifestyle company in China. The company uses an omnichannel approach with its self operated ecommerce platform O’Mall, live streaming sales, third party sellers and offline sales. The company has 2.1 million active buyers and 15.5 million registered users.\niPower:Online hydroponic equipment selleriPower IncNASDAQIPWplansto offer 5 million shares at a price point of $9 to $11. The company offers its own brands and partnered brands through its websitewww.zenhydro.com. iPower-owned brands represented 76% of company sales in the six month period ending December 31, 2020. The company had sales of $26.2 million in the six month period ending December 31, 2020. Preliminary first-quarter revenue is expected to be in a range of $11.75 million to $12.75 million compared to $9.4 million in the prior year.","news_type":1,"symbols_score_info":{"IPW":0.9}},"isVote":1,"tweetType":1,"viewCount":2295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106282534,"gmtCreate":1620124291528,"gmtModify":1704338958399,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580604694268529","authorIdStr":"3580604694268529"},"themes":[],"htmlText":"Help comment and like please","listText":"Help comment and like please","text":"Help comment and like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/106282534","repostId":"1157490418","repostType":4,"repost":{"id":"1157490418","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620120727,"share":"https://ttm.financial/m/news/1157490418?lang=en_US&edition=fundamental","pubTime":"2021-05-04 17:32","market":"us","language":"en","title":"After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1157490418","media":"Tiger Newspress","summary":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares ","content":"<p style=\"text-align:left;\">(May 4)&nbsp;After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p>Shares of&nbsp;<b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><b>So what</b></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><b>Now what</b></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter surging nearly 24% yesterday, OCGN dipped 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-04 17:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p style=\"text-align:left;\">(May 4)&nbsp;After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p>Shares of&nbsp;<b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><b>So what</b></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><b>Now what</b></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157490418","content_text":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares of Ocugen(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.So whatResearchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"Now whatMusunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106282107,"gmtCreate":1620124242009,"gmtModify":1704338957739,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580604694268529","authorIdStr":"3580604694268529"},"themes":[],"htmlText":"Hihi","listText":"Hihi","text":"Hihi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/106282107","repostId":"1157490418","repostType":4,"repost":{"id":"1157490418","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620120727,"share":"https://ttm.financial/m/news/1157490418?lang=en_US&edition=fundamental","pubTime":"2021-05-04 17:32","market":"us","language":"en","title":"After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1157490418","media":"Tiger Newspress","summary":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares ","content":"<p style=\"text-align:left;\">(May 4)&nbsp;After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p>Shares of&nbsp;<b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><b>So what</b></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><b>Now what</b></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter surging nearly 24% yesterday, OCGN dipped 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-04 17:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p style=\"text-align:left;\">(May 4)&nbsp;After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p>Shares of&nbsp;<b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><b>So what</b></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><b>Now what</b></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157490418","content_text":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares of Ocugen(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.So whatResearchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"Now whatMusunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2346,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101743477,"gmtCreate":1619950225799,"gmtModify":1704336712883,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580604694268529","authorIdStr":"3580604694268529"},"themes":[],"htmlText":"Hi like and comment please","listText":"Hi like and comment please","text":"Hi like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/101743477","repostId":"1103106179","repostType":4,"isVote":1,"tweetType":1,"viewCount":2178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101929456,"gmtCreate":1619838218775,"gmtModify":1704335594622,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580604694268529","authorIdStr":"3580604694268529"},"themes":[],"htmlText":"Hi everyone like and comment please!","listText":"Hi everyone like and comment please!","text":"Hi everyone like and comment please!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/101929456","repostId":"1146129324","repostType":4,"repost":{"id":"1146129324","kind":"news","pubTimestamp":1619795610,"share":"https://ttm.financial/m/news/1146129324?lang=en_US&edition=fundamental","pubTime":"2021-04-30 23:13","market":"us","language":"en","title":"1 Question Tesla Investors Need to Ask Themselves","url":"https://stock-news.laohu8.com/highlight/detail?id=1146129324","media":"Motley Fool","summary":"Electric-car companyTeslahas now produced a profit for seven consecutive quarters. Tesla managed aGAAPnet income of $438 million in the first quarter, up from just $16 million one-year prior. It would appear, at least at first glance, that the electric-vehicle  pioneer is on the right track in terms of profitability.The problem is that these profits aren't really coming from the cars that Tesla sells. The company currently generates hundreds of millions of dollars in pure profit each quarter fro","content":"<p>Electric-car company<b>Tesla</b>(NASDAQ:TSLA)has now produced a profit for seven consecutive quarters. Tesla managed aGAAPnet income of $438 million in the first quarter, up from just $16 million one-year prior. It would appear, at least at first glance, that the electric-vehicle (EV) pioneer is on the right track in terms of profitability.</p>\n<p>The problem is that these profits aren't really coming from the cars that Tesla sells. The company currently generates hundreds of millions of dollars in pure profit each quarter from the sale of regulatory credits, a side effect of other automakers not making enough zero-emission vehicles to meet regulatory requirements.</p>\n<p>Regulatory credit sales totaled $518 million in the first quarter, accounting for all of Tesla's profit and then some. This has been the case in previous quarters, as well. In fact, after backing out regulatory credits from Tesla's net income, the company has been unprofitable for six-straight quarters.</p>\n<p>Tesla's bottom line got an additional boost in the first quarter from a gain onthe sale of<b>Bitcoin</b>to the tune of $101 million, which showed up as a reduction in costs. The picture doesn't look so rosy when both regulatory credits and Bitcoin gains are excluded:</p>\n<p><img src=\"https://static.tigerbbs.com/b0906160cab581f4c8a599b7d0965d34\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p>\n<p>DATA SOURCE: TESLA. CHART BY AUTHOR.</p>\n<p>There's no question that Tesla's growth is impressive, but there's also no question that the core business of making and selling cars is not turning a profit. The question Tesla investors need to ask themselves is: If Tesla isn't profitable now, when there's little to no competition in electric vehicles in the United States, what's going to happen when a deluge of competition fromtraditional automakersarrives?</p>\n<p>A ton of competition is coming</p>\n<p>Tesla's brand has a cult following, so some people will be buying Tesla vehicles regardless of the other options available. But that's not likely to be the case for most people.</p>\n<p>The number of electric vehicles available for purchase in the U.S. is set to explode in the coming years.<b>General Motors</b>(NYSE:GM)is planning to launch 30 EVs globally by 2025, with two-thirds set to be sold in North America. The company is aiming to sell 1 million EVs annually in North America by 2025.</p>\n<p>Those models include electric versions of the company's GMC Hummer and Chevrolet Silverado pickup truck. Tesla has a loyal customer base, but so does GM. Someone who's been a GM truck buyer for years is likely to stick with GM when they decide to switch to an electric vehicle.</p>\n<p><img src=\"https://static.tigerbbs.com/c651279799dfdf96552379a7b5d448a9\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>IMAGE SOURCE: GM.</p>\n<p><b>Ford</b>(NYSE:F)is also pouring resources into electric vehicles, allocating $29 billion for electric and autonomous vehicles through 2025. The company's plans include anelectric version of its F-150 pickup truck, which should hit the production lines by mid-2022. Given GM's and Ford's plans, it will not be easy for Tesla to steal away market share in the lucrative pickup-truck segment.</p>\n<p>Other car companies have big plans, as well.<b>Volkswagen</b>(OTC:VWAGY)already sells over 200,000 EVs annually andexpects that number to double this year. The company is aiming to sell roughly 2 million EVs annually by 2025 and expects to launch 70 EV models by 2030.<b>Toyota</b>(NYSE:TM)willlaunch 15 new electric vehicles by 2025, some of which will be under the new Toyota bZ sub-brand. The list goes on.</p>\n<p>Not only will all these electric vehicles provide consumers with a bevy of options beyond Tesla, but they'll also deprive Tesla of its regulatory-credit income as other automakers churn out an increasing number of EVs.</p>\n<p>None of this is to say that Tesla can't be successful in a world where it faces more competition. But turning a profit is is going to get harder with each passing year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>1 Question Tesla Investors Need to Ask Themselves</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n1 Question Tesla Investors Need to Ask Themselves\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 23:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/30/1-question-tesla-investors-need-to-ask-themselves/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Electric-car companyTesla(NASDAQ:TSLA)has now produced a profit for seven consecutive quarters. Tesla managed aGAAPnet income of $438 million in the first quarter, up from just $16 million one-year ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/30/1-question-tesla-investors-need-to-ask-themselves/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.fool.com/investing/2021/04/30/1-question-tesla-investors-need-to-ask-themselves/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146129324","content_text":"Electric-car companyTesla(NASDAQ:TSLA)has now produced a profit for seven consecutive quarters. Tesla managed aGAAPnet income of $438 million in the first quarter, up from just $16 million one-year prior. It would appear, at least at first glance, that the electric-vehicle (EV) pioneer is on the right track in terms of profitability.\nThe problem is that these profits aren't really coming from the cars that Tesla sells. The company currently generates hundreds of millions of dollars in pure profit each quarter from the sale of regulatory credits, a side effect of other automakers not making enough zero-emission vehicles to meet regulatory requirements.\nRegulatory credit sales totaled $518 million in the first quarter, accounting for all of Tesla's profit and then some. This has been the case in previous quarters, as well. In fact, after backing out regulatory credits from Tesla's net income, the company has been unprofitable for six-straight quarters.\nTesla's bottom line got an additional boost in the first quarter from a gain onthe sale ofBitcointo the tune of $101 million, which showed up as a reduction in costs. The picture doesn't look so rosy when both regulatory credits and Bitcoin gains are excluded:\n\nDATA SOURCE: TESLA. CHART BY AUTHOR.\nThere's no question that Tesla's growth is impressive, but there's also no question that the core business of making and selling cars is not turning a profit. The question Tesla investors need to ask themselves is: If Tesla isn't profitable now, when there's little to no competition in electric vehicles in the United States, what's going to happen when a deluge of competition fromtraditional automakersarrives?\nA ton of competition is coming\nTesla's brand has a cult following, so some people will be buying Tesla vehicles regardless of the other options available. But that's not likely to be the case for most people.\nThe number of electric vehicles available for purchase in the U.S. is set to explode in the coming years.General Motors(NYSE:GM)is planning to launch 30 EVs globally by 2025, with two-thirds set to be sold in North America. The company is aiming to sell 1 million EVs annually in North America by 2025.\nThose models include electric versions of the company's GMC Hummer and Chevrolet Silverado pickup truck. Tesla has a loyal customer base, but so does GM. Someone who's been a GM truck buyer for years is likely to stick with GM when they decide to switch to an electric vehicle.\n\nIMAGE SOURCE: GM.\nFord(NYSE:F)is also pouring resources into electric vehicles, allocating $29 billion for electric and autonomous vehicles through 2025. The company's plans include anelectric version of its F-150 pickup truck, which should hit the production lines by mid-2022. Given GM's and Ford's plans, it will not be easy for Tesla to steal away market share in the lucrative pickup-truck segment.\nOther car companies have big plans, as well.Volkswagen(OTC:VWAGY)already sells over 200,000 EVs annually andexpects that number to double this year. The company is aiming to sell roughly 2 million EVs annually by 2025 and expects to launch 70 EV models by 2030.Toyota(NYSE:TM)willlaunch 15 new electric vehicles by 2025, some of which will be under the new Toyota bZ sub-brand. The list goes on.\nNot only will all these electric vehicles provide consumers with a bevy of options beyond Tesla, but they'll also deprive Tesla of its regulatory-credit income as other automakers churn out an increasing number of EVs.\nNone of this is to say that Tesla can't be successful in a world where it faces more competition. But turning a profit is is going to get harder with each passing year.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":2529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374917607,"gmtCreate":1619408839109,"gmtModify":1704723401178,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580604694268529","authorIdStr":"3580604694268529"},"themes":[],"htmlText":"Comment please","listText":"Comment please","text":"Comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/374917607","repostId":"1184404050","repostType":4,"isVote":1,"tweetType":1,"viewCount":2544,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374918133,"gmtCreate":1619408364622,"gmtModify":1704723393855,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580604694268529","authorIdStr":"3580604694268529"},"themes":[],"htmlText":"Lets all watch ocgn!! EUA","listText":"Lets all watch ocgn!! EUA","text":"Lets all watch ocgn!! EUA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/374918133","repostId":"1184404050","repostType":4,"isVote":1,"tweetType":1,"viewCount":1605,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374911146,"gmtCreate":1619408313185,"gmtModify":1704723392398,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580604694268529","authorIdStr":"3580604694268529"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/374911146","repostId":"2129296363","repostType":4,"repost":{"id":"2129296363","kind":"highlight","pubTimestamp":1619407680,"share":"https://ttm.financial/m/news/2129296363?lang=en_US&edition=fundamental","pubTime":"2021-04-26 11:28","market":"us","language":"en","title":"The psychology of a stock market bubble","url":"https://stock-news.laohu8.com/highlight/detail?id=2129296363","media":"MarketWatch","summary":"Worry about a bubble is widespread at the top of a bubbleSometimes people are drawn to investing bec","content":"<p>Worry about a bubble is widespread at the top of a bubble</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6aee1d89d41ff471a9548f988bd7c4fd\" tg-width=\"1260\" tg-height=\"840\" referrerpolicy=\"no-referrer\"><span>Sometimes people are drawn to investing because of 'gambler's excitement' Getty Images/iStockphoto</span></p><p>I have no idea whether the stock market is actually forming a bubble that's about to break.</p><p>But I do know that many bulls are fooling themselves when they think a bubble can't happen when so many of us are concerned about <a href=\"https://laohu8.com/S/AONE\">one</a>. In fact, <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the distinguishing characteristics of a bubble is that such concern is widespread.</p><p>This seems counterintuitive. You would think that a bubble is most vulnerable to forming and then popping when investors are oblivious to that possibility. But you would be wrong.</p><p>It's important for all of us to be aware of this bubble psychology, but especially if you're a retiree or a near-retiree. That's because, in that case, your investment horizon will be shorter than for those who are younger, and you therefore are less able to recover from the deflation of a market bubble.</p><p>To appreciate how widespread current concern about a bubble is, consider the accompanying chart of data from Google Trends. It plots the relative frequency of Google searches based on the term \"stock market bubble.\" Notice that this frequency has recently jumped to a far-higher level than at any other point over the last five years.</p><p><img src=\"https://static.tigerbbs.com/10c79372e12449d1f3e00acd1666c914\" tg-width=\"1260\" tg-height=\"849\" referrerpolicy=\"no-referrer\"></p><p>This widespread concern is entirely consistent with a bubble's formation, according to a definition proposed several decades ago by Robert Shiller, the Yale finance professor and Nobel laureate. According to him, a bubble is \"a market situation in which news of price increases spurs investor enthusiasm which spreads by psychological contagion from person to person, bringing in a larger and larger class of investors, who, despite doubts about fundamental value, are drawn to the investment partly through envy of others' successes and partly through a gambler's excitement.\" (I italicized the above phrase, not Shiller.)</p><p>Notice that recognition of overvaluation is an integral part of the definition.</p><p>This recognition was certainly present during the weeks and months prior to the popping of the Internet bubble in March 2000. During the early and middle years of the 1990s, you may recall, it was possible to justify higher prices while keeping a straight face. But that became less and less possible as prices continued going higher in the late 1990s, and especially as some dot-com companies went public with huge valuations despite having no assets, revenue or business plan.</p><p>Rather than responding by taking some chips off the table, however, many began freely admitting that a bubble was forming. They no longer tried to justify higher prices on fundamentals, but began justifying it instead in terms of the market's momentum. Prices should keep going up as FOMO seduces more and more investors to jump on the bandwagon.</p><p>There is no shortage of current analogies, of course. Take dogecoin, which was created as a joke and has no fundamental value. As a recent Wall Street Journal article outlined , the dogecoin \"serves no purpose and, unlike Bitcoin, faces no limit on the number of coins that exist.\" Yet investors are flocking to it, for no other apparent reason than it has already gone up so much. Billy Markus, the co-creator of dogecoin, was quoted in that Wall Street Journal article saying \"This is absurd. I haven't seen anything like it. It's one of those things that once it starts going up, it might keep going up.\"</p><p>Needless to say, things don't go up forever. Those who nevertheless continue to invest in such an environment do so with the implicit assumption that they will be able to recognize it, in advance, when the bubble is about to pop--and therefore able to leave the party before everyone else. This is a dangerous delusion, however; not everyone can be the first to leave the party.</p><p>The bottom line? Far from being a reason why a bubble isn't forming, the widespread current concern about a possible bubble is actually a reason to worry that it could be. Take heed.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The psychology of a stock market bubble</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe psychology of a stock market bubble\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-26 11:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/the-psychology-of-a-stock-market-bubble-11619198164?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Worry about a bubble is widespread at the top of a bubbleSometimes people are drawn to investing because of 'gambler's excitement' Getty Images/iStockphotoI have no idea whether the stock market is ...</p>\n\n<a href=\"https://www.marketwatch.com/story/the-psychology-of-a-stock-market-bubble-11619198164?mod=home-page\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/story/the-psychology-of-a-stock-market-bubble-11619198164?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2129296363","content_text":"Worry about a bubble is widespread at the top of a bubbleSometimes people are drawn to investing because of 'gambler's excitement' Getty Images/iStockphotoI have no idea whether the stock market is actually forming a bubble that's about to break.But I do know that many bulls are fooling themselves when they think a bubble can't happen when so many of us are concerned about one. In fact, one of the distinguishing characteristics of a bubble is that such concern is widespread.This seems counterintuitive. You would think that a bubble is most vulnerable to forming and then popping when investors are oblivious to that possibility. But you would be wrong.It's important for all of us to be aware of this bubble psychology, but especially if you're a retiree or a near-retiree. That's because, in that case, your investment horizon will be shorter than for those who are younger, and you therefore are less able to recover from the deflation of a market bubble.To appreciate how widespread current concern about a bubble is, consider the accompanying chart of data from Google Trends. It plots the relative frequency of Google searches based on the term \"stock market bubble.\" Notice that this frequency has recently jumped to a far-higher level than at any other point over the last five years.This widespread concern is entirely consistent with a bubble's formation, according to a definition proposed several decades ago by Robert Shiller, the Yale finance professor and Nobel laureate. According to him, a bubble is \"a market situation in which news of price increases spurs investor enthusiasm which spreads by psychological contagion from person to person, bringing in a larger and larger class of investors, who, despite doubts about fundamental value, are drawn to the investment partly through envy of others' successes and partly through a gambler's excitement.\" (I italicized the above phrase, not Shiller.)Notice that recognition of overvaluation is an integral part of the definition.This recognition was certainly present during the weeks and months prior to the popping of the Internet bubble in March 2000. During the early and middle years of the 1990s, you may recall, it was possible to justify higher prices while keeping a straight face. But that became less and less possible as prices continued going higher in the late 1990s, and especially as some dot-com companies went public with huge valuations despite having no assets, revenue or business plan.Rather than responding by taking some chips off the table, however, many began freely admitting that a bubble was forming. They no longer tried to justify higher prices on fundamentals, but began justifying it instead in terms of the market's momentum. Prices should keep going up as FOMO seduces more and more investors to jump on the bandwagon.There is no shortage of current analogies, of course. Take dogecoin, which was created as a joke and has no fundamental value. As a recent Wall Street Journal article outlined , the dogecoin \"serves no purpose and, unlike Bitcoin, faces no limit on the number of coins that exist.\" Yet investors are flocking to it, for no other apparent reason than it has already gone up so much. Billy Markus, the co-creator of dogecoin, was quoted in that Wall Street Journal article saying \"This is absurd. I haven't seen anything like it. It's one of those things that once it starts going up, it might keep going up.\"Needless to say, things don't go up forever. Those who nevertheless continue to invest in such an environment do so with the implicit assumption that they will be able to recognize it, in advance, when the bubble is about to pop--and therefore able to leave the party before everyone else. This is a dangerous delusion, however; not everyone can be the first to leave the party.The bottom line? Far from being a reason why a bubble isn't forming, the widespread current concern about a possible bubble is actually a reason to worry that it could be. Take heed.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":1913,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374919286,"gmtCreate":1619408149545,"gmtModify":1704723390130,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580604694268529","authorIdStr":"3580604694268529"},"themes":[],"htmlText":"Hi like and comment please","listText":"Hi like and comment please","text":"Hi like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/374919286","repostId":"1184404050","repostType":4,"isVote":1,"tweetType":1,"viewCount":2497,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":374917607,"gmtCreate":1619408839109,"gmtModify":1704723401178,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580604694268529","idStr":"3580604694268529"},"themes":[],"htmlText":"Comment please","listText":"Comment please","text":"Comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/374917607","repostId":"1184404050","repostType":4,"isVote":1,"tweetType":1,"viewCount":2544,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106717072,"gmtCreate":1620145388796,"gmtModify":1704339354625,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580604694268529","idStr":"3580604694268529"},"themes":[],"htmlText":"&nbsp;Hihihihi like and comment please","listText":"&nbsp;Hihihihi like and comment please","text":"Hihihihi like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/106717072","repostId":"1191168108","repostType":4,"repost":{"id":"1191168108","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1620139872,"share":"https://ttm.financial/m/news/1191168108?lang=en_US&edition=fundamental","pubTime":"2021-05-04 22:51","market":"us","language":"en","title":"IPO Preview: Honest Company, Chinese Lifestyle Brand Onion Global, Hydroponic iPower Lead Group","url":"https://stock-news.laohu8.com/highlight/detail?id=1191168108","media":"Benzinga","summary":"The week of May 3 has several IPOs on the docket spread across sectors like consumer products, fashi","content":"<p>The week of May 3 has several IPOs on the docket spread across sectors like consumer products, fashion, banking, vaccines and hydroponics. Here is a look at this week’s top offerings and details investors should know.</p>\n<p><b>Waterdrop:</b>Working with insurance companies,<b>Waterdrop</b>NYSEWDHseeksto have a positive social impact with its technology platform. Waterdrop has over 79.4 million cumulative customers and over 340 million donors to its crowdfunding platform, which is the largest medical crowdfunding platform in China.</p>\n<p>Waterdrop works with 62 insurance carriers and offers over 200 products to help customers and those seeking help with medical bills. The company had revenue of $464.1 million in fiscal 2020. The company plans on offering 30 million American depositary shares at a price point of $10 to $12.</p>\n<p><b>Five Star Bancorp:</b>With branches in California,<b>Five Star Bancorp</b>NASDAQFSBCisa regional bank company focused on the Sacramento market. The company ended 2020 with $1.8 billion in deposits and $1.5 billion in loans.</p>\n<p>From 2016 to 2020, the company saw compounded annual growth of 23.5% for assets, 23.8% for loans and 23.7% for deposits. First quarter preliminary numbers saw deposits grow 11.2% from the fourth quarter and loans grow 2.6% from the fourth quarter. The company plans on selling 5.265 million shares at a price point of $18 to $20.</p>\n<p><b>The Honest Company:</b>Clean lifestyle product company<b>The Honest Company</b>NASDAQHNSTcouldbe the most-watched IPO this week. The company was founded by actress Jessica Alba in 2012 in response to finding clean products and non-allergic reactions from products after giving birth.</p>\n<p>The Honest Company prides itself in being “a conscious living company for today and tomorrow.” The company has grown from being a diapers-and-wipes company to covering every age and every life stage of its customers.</p>\n<p>The Honest Company had revenue of $235.6 million in fiscal 2020, up 27.6% year-over-year. Diapers and wipes made up 63% of 2020 revenue, up 16.4% year-over-year. Skin and personal care product revenue represented 26% of sales in 2020 and were up 55% year-over-year. Household and wellness sales made up 11% of sales and had year-over-year growth of 116.5% in 2020. The Honest Company products can be purchased online from the company or sites like<b>Amazon.com</b>AMZN 1.77%and in physical stores like<b>Costco Wholesale Corporation</b>COST 0.54%and<b>Target Corporation</b>TGT 0.23%.</p>\n<p>Founder Alba will not sell any shares in the IPO and will own an estimated 6.1% of the company after the offering. The company isseekingto sell 25.8 million shares at a price point of $14 to $17.</p>\n<p><b>Bowman Consulting Group:</b>Professional services company<b>Bowman Consulting Group</b>NASDAQBWMNoffersengineering solutions to customers. Bowman Consulting has over 2,200 customers who count on the company for services like planning, engineering, construction management, commissioning, geomatics, survey, land procurement and environmental consulting. The company had revenue of $122 million in the last fiscal year, up from $113.7 million in the prior year. Bowman Consulting plans to offer 3.1 million shares at a price point of $12 to $14.</p>\n<p><b>Valneva:</b>Vaccine company<b>Valneva</b>NASDAQVLAplansto sell 7.1 million ordinary shares (3.55 million ADSs) at a price of $28.24. The company is focused on vaccine development in infectious diseases. Target areas include Lyme disease, the Chikungunya virus and COVID-19. The company’s lead program VLA15 is in Phase 2 trials to treat Lyme disease and is partnered with<b>Pfizer Corporation</b>PFE 0.49%. Other clinical trials include VLA1553 to treat Chikungunya virus and VLA2001 to treat COVID-19. The company’s VLA1553 is the only known Phase 3 trial vaccine to treat Chikungunya, which could put it in the spotlight with spread to over 100 countries. Several of the company’s products have received Fast Track designation by the FDA.</p>\n<p><b>Onion Global:</b>Lifestyle brand company<b>Onion Global</b>NYSEOGplanson selling 12.5 million ADS at a price point of $7.25 to $9.25. The company targets fresh, fashionable and future brands, which it refers to as the 3Fs across China and parts of Asia. The company has over 4,000 brands in 23 categories sold in 43 countries. Onion Global is a top ten global lifestyle company in China. The company uses an omnichannel approach with its self operated ecommerce platform O’Mall, live streaming sales, third party sellers and offline sales. The company has 2.1 million active buyers and 15.5 million registered users.</p>\n<p><b>iPower:</b>Online hydroponic equipment seller<b>iPower Inc</b>NASDAQIPWplansto offer 5&nbsp;million shares at a price point of $9 to $11. The company offers its own brands and partnered brands through its websitewww.zenhydro.com. iPower-owned brands represented 76% of company sales in the six month period ending December 31, 2020. The company had sales of $26.2 million in the six month period ending December 31, 2020. Preliminary first-quarter revenue is expected to be in a range of $11.75 million to $12.75 million compared to $9.4 million in the prior year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO Preview: Honest Company, Chinese Lifestyle Brand Onion Global, Hydroponic iPower Lead Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO Preview: Honest Company, Chinese Lifestyle Brand Onion Global, Hydroponic iPower Lead Group\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-05-04 22:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The week of May 3 has several IPOs on the docket spread across sectors like consumer products, fashion, banking, vaccines and hydroponics. Here is a look at this week’s top offerings and details investors should know.</p>\n<p><b>Waterdrop:</b>Working with insurance companies,<b>Waterdrop</b>NYSEWDHseeksto have a positive social impact with its technology platform. Waterdrop has over 79.4 million cumulative customers and over 340 million donors to its crowdfunding platform, which is the largest medical crowdfunding platform in China.</p>\n<p>Waterdrop works with 62 insurance carriers and offers over 200 products to help customers and those seeking help with medical bills. The company had revenue of $464.1 million in fiscal 2020. The company plans on offering 30 million American depositary shares at a price point of $10 to $12.</p>\n<p><b>Five Star Bancorp:</b>With branches in California,<b>Five Star Bancorp</b>NASDAQFSBCisa regional bank company focused on the Sacramento market. The company ended 2020 with $1.8 billion in deposits and $1.5 billion in loans.</p>\n<p>From 2016 to 2020, the company saw compounded annual growth of 23.5% for assets, 23.8% for loans and 23.7% for deposits. First quarter preliminary numbers saw deposits grow 11.2% from the fourth quarter and loans grow 2.6% from the fourth quarter. The company plans on selling 5.265 million shares at a price point of $18 to $20.</p>\n<p><b>The Honest Company:</b>Clean lifestyle product company<b>The Honest Company</b>NASDAQHNSTcouldbe the most-watched IPO this week. The company was founded by actress Jessica Alba in 2012 in response to finding clean products and non-allergic reactions from products after giving birth.</p>\n<p>The Honest Company prides itself in being “a conscious living company for today and tomorrow.” The company has grown from being a diapers-and-wipes company to covering every age and every life stage of its customers.</p>\n<p>The Honest Company had revenue of $235.6 million in fiscal 2020, up 27.6% year-over-year. Diapers and wipes made up 63% of 2020 revenue, up 16.4% year-over-year. Skin and personal care product revenue represented 26% of sales in 2020 and were up 55% year-over-year. Household and wellness sales made up 11% of sales and had year-over-year growth of 116.5% in 2020. The Honest Company products can be purchased online from the company or sites like<b>Amazon.com</b>AMZN 1.77%and in physical stores like<b>Costco Wholesale Corporation</b>COST 0.54%and<b>Target Corporation</b>TGT 0.23%.</p>\n<p>Founder Alba will not sell any shares in the IPO and will own an estimated 6.1% of the company after the offering. The company isseekingto sell 25.8 million shares at a price point of $14 to $17.</p>\n<p><b>Bowman Consulting Group:</b>Professional services company<b>Bowman Consulting Group</b>NASDAQBWMNoffersengineering solutions to customers. Bowman Consulting has over 2,200 customers who count on the company for services like planning, engineering, construction management, commissioning, geomatics, survey, land procurement and environmental consulting. The company had revenue of $122 million in the last fiscal year, up from $113.7 million in the prior year. Bowman Consulting plans to offer 3.1 million shares at a price point of $12 to $14.</p>\n<p><b>Valneva:</b>Vaccine company<b>Valneva</b>NASDAQVLAplansto sell 7.1 million ordinary shares (3.55 million ADSs) at a price of $28.24. The company is focused on vaccine development in infectious diseases. Target areas include Lyme disease, the Chikungunya virus and COVID-19. The company’s lead program VLA15 is in Phase 2 trials to treat Lyme disease and is partnered with<b>Pfizer Corporation</b>PFE 0.49%. Other clinical trials include VLA1553 to treat Chikungunya virus and VLA2001 to treat COVID-19. The company’s VLA1553 is the only known Phase 3 trial vaccine to treat Chikungunya, which could put it in the spotlight with spread to over 100 countries. Several of the company’s products have received Fast Track designation by the FDA.</p>\n<p><b>Onion Global:</b>Lifestyle brand company<b>Onion Global</b>NYSEOGplanson selling 12.5 million ADS at a price point of $7.25 to $9.25. The company targets fresh, fashionable and future brands, which it refers to as the 3Fs across China and parts of Asia. The company has over 4,000 brands in 23 categories sold in 43 countries. Onion Global is a top ten global lifestyle company in China. The company uses an omnichannel approach with its self operated ecommerce platform O’Mall, live streaming sales, third party sellers and offline sales. The company has 2.1 million active buyers and 15.5 million registered users.</p>\n<p><b>iPower:</b>Online hydroponic equipment seller<b>iPower Inc</b>NASDAQIPWplansto offer 5&nbsp;million shares at a price point of $9 to $11. The company offers its own brands and partnered brands through its websitewww.zenhydro.com. iPower-owned brands represented 76% of company sales in the six month period ending December 31, 2020. The company had sales of $26.2 million in the six month period ending December 31, 2020. Preliminary first-quarter revenue is expected to be in a range of $11.75 million to $12.75 million compared to $9.4 million in the prior year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IPW":"iPower Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191168108","content_text":"The week of May 3 has several IPOs on the docket spread across sectors like consumer products, fashion, banking, vaccines and hydroponics. Here is a look at this week’s top offerings and details investors should know.\nWaterdrop:Working with insurance companies,WaterdropNYSEWDHseeksto have a positive social impact with its technology platform. Waterdrop has over 79.4 million cumulative customers and over 340 million donors to its crowdfunding platform, which is the largest medical crowdfunding platform in China.\nWaterdrop works with 62 insurance carriers and offers over 200 products to help customers and those seeking help with medical bills. The company had revenue of $464.1 million in fiscal 2020. The company plans on offering 30 million American depositary shares at a price point of $10 to $12.\nFive Star Bancorp:With branches in California,Five Star BancorpNASDAQFSBCisa regional bank company focused on the Sacramento market. The company ended 2020 with $1.8 billion in deposits and $1.5 billion in loans.\nFrom 2016 to 2020, the company saw compounded annual growth of 23.5% for assets, 23.8% for loans and 23.7% for deposits. First quarter preliminary numbers saw deposits grow 11.2% from the fourth quarter and loans grow 2.6% from the fourth quarter. The company plans on selling 5.265 million shares at a price point of $18 to $20.\nThe Honest Company:Clean lifestyle product companyThe Honest CompanyNASDAQHNSTcouldbe the most-watched IPO this week. The company was founded by actress Jessica Alba in 2012 in response to finding clean products and non-allergic reactions from products after giving birth.\nThe Honest Company prides itself in being “a conscious living company for today and tomorrow.” The company has grown from being a diapers-and-wipes company to covering every age and every life stage of its customers.\nThe Honest Company had revenue of $235.6 million in fiscal 2020, up 27.6% year-over-year. Diapers and wipes made up 63% of 2020 revenue, up 16.4% year-over-year. Skin and personal care product revenue represented 26% of sales in 2020 and were up 55% year-over-year. Household and wellness sales made up 11% of sales and had year-over-year growth of 116.5% in 2020. The Honest Company products can be purchased online from the company or sites likeAmazon.comAMZN 1.77%and in physical stores likeCostco Wholesale CorporationCOST 0.54%andTarget CorporationTGT 0.23%.\nFounder Alba will not sell any shares in the IPO and will own an estimated 6.1% of the company after the offering. The company isseekingto sell 25.8 million shares at a price point of $14 to $17.\nBowman Consulting Group:Professional services companyBowman Consulting GroupNASDAQBWMNoffersengineering solutions to customers. Bowman Consulting has over 2,200 customers who count on the company for services like planning, engineering, construction management, commissioning, geomatics, survey, land procurement and environmental consulting. The company had revenue of $122 million in the last fiscal year, up from $113.7 million in the prior year. Bowman Consulting plans to offer 3.1 million shares at a price point of $12 to $14.\nValneva:Vaccine companyValnevaNASDAQVLAplansto sell 7.1 million ordinary shares (3.55 million ADSs) at a price of $28.24. The company is focused on vaccine development in infectious diseases. Target areas include Lyme disease, the Chikungunya virus and COVID-19. The company’s lead program VLA15 is in Phase 2 trials to treat Lyme disease and is partnered withPfizer CorporationPFE 0.49%. Other clinical trials include VLA1553 to treat Chikungunya virus and VLA2001 to treat COVID-19. The company’s VLA1553 is the only known Phase 3 trial vaccine to treat Chikungunya, which could put it in the spotlight with spread to over 100 countries. Several of the company’s products have received Fast Track designation by the FDA.\nOnion Global:Lifestyle brand companyOnion GlobalNYSEOGplanson selling 12.5 million ADS at a price point of $7.25 to $9.25. The company targets fresh, fashionable and future brands, which it refers to as the 3Fs across China and parts of Asia. The company has over 4,000 brands in 23 categories sold in 43 countries. Onion Global is a top ten global lifestyle company in China. The company uses an omnichannel approach with its self operated ecommerce platform O’Mall, live streaming sales, third party sellers and offline sales. The company has 2.1 million active buyers and 15.5 million registered users.\niPower:Online hydroponic equipment selleriPower IncNASDAQIPWplansto offer 5 million shares at a price point of $9 to $11. The company offers its own brands and partnered brands through its websitewww.zenhydro.com. iPower-owned brands represented 76% of company sales in the six month period ending December 31, 2020. The company had sales of $26.2 million in the six month period ending December 31, 2020. Preliminary first-quarter revenue is expected to be in a range of $11.75 million to $12.75 million compared to $9.4 million in the prior year.","news_type":1,"symbols_score_info":{"IPW":0.9}},"isVote":1,"tweetType":1,"viewCount":2295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101743477,"gmtCreate":1619950225799,"gmtModify":1704336712883,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580604694268529","idStr":"3580604694268529"},"themes":[],"htmlText":"Hi like and comment please","listText":"Hi like and comment please","text":"Hi like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/101743477","repostId":"1103106179","repostType":4,"isVote":1,"tweetType":1,"viewCount":2178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374919286,"gmtCreate":1619408149545,"gmtModify":1704723390130,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580604694268529","idStr":"3580604694268529"},"themes":[],"htmlText":"Hi like and comment please","listText":"Hi like and comment please","text":"Hi like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/374919286","repostId":"1184404050","repostType":4,"isVote":1,"tweetType":1,"viewCount":2497,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":101929456,"gmtCreate":1619838218775,"gmtModify":1704335594622,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580604694268529","idStr":"3580604694268529"},"themes":[],"htmlText":"Hi everyone like and comment please!","listText":"Hi everyone like and comment please!","text":"Hi everyone like and comment please!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/101929456","repostId":"1146129324","repostType":4,"repost":{"id":"1146129324","kind":"news","pubTimestamp":1619795610,"share":"https://ttm.financial/m/news/1146129324?lang=en_US&edition=fundamental","pubTime":"2021-04-30 23:13","market":"us","language":"en","title":"1 Question Tesla Investors Need to Ask Themselves","url":"https://stock-news.laohu8.com/highlight/detail?id=1146129324","media":"Motley Fool","summary":"Electric-car companyTeslahas now produced a profit for seven consecutive quarters. Tesla managed aGAAPnet income of $438 million in the first quarter, up from just $16 million one-year prior. It would appear, at least at first glance, that the electric-vehicle  pioneer is on the right track in terms of profitability.The problem is that these profits aren't really coming from the cars that Tesla sells. The company currently generates hundreds of millions of dollars in pure profit each quarter fro","content":"<p>Electric-car company<b>Tesla</b>(NASDAQ:TSLA)has now produced a profit for seven consecutive quarters. Tesla managed aGAAPnet income of $438 million in the first quarter, up from just $16 million one-year prior. It would appear, at least at first glance, that the electric-vehicle (EV) pioneer is on the right track in terms of profitability.</p>\n<p>The problem is that these profits aren't really coming from the cars that Tesla sells. The company currently generates hundreds of millions of dollars in pure profit each quarter from the sale of regulatory credits, a side effect of other automakers not making enough zero-emission vehicles to meet regulatory requirements.</p>\n<p>Regulatory credit sales totaled $518 million in the first quarter, accounting for all of Tesla's profit and then some. This has been the case in previous quarters, as well. In fact, after backing out regulatory credits from Tesla's net income, the company has been unprofitable for six-straight quarters.</p>\n<p>Tesla's bottom line got an additional boost in the first quarter from a gain onthe sale of<b>Bitcoin</b>to the tune of $101 million, which showed up as a reduction in costs. The picture doesn't look so rosy when both regulatory credits and Bitcoin gains are excluded:</p>\n<p><img src=\"https://static.tigerbbs.com/b0906160cab581f4c8a599b7d0965d34\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p>\n<p>DATA SOURCE: TESLA. CHART BY AUTHOR.</p>\n<p>There's no question that Tesla's growth is impressive, but there's also no question that the core business of making and selling cars is not turning a profit. The question Tesla investors need to ask themselves is: If Tesla isn't profitable now, when there's little to no competition in electric vehicles in the United States, what's going to happen when a deluge of competition fromtraditional automakersarrives?</p>\n<p>A ton of competition is coming</p>\n<p>Tesla's brand has a cult following, so some people will be buying Tesla vehicles regardless of the other options available. But that's not likely to be the case for most people.</p>\n<p>The number of electric vehicles available for purchase in the U.S. is set to explode in the coming years.<b>General Motors</b>(NYSE:GM)is planning to launch 30 EVs globally by 2025, with two-thirds set to be sold in North America. The company is aiming to sell 1 million EVs annually in North America by 2025.</p>\n<p>Those models include electric versions of the company's GMC Hummer and Chevrolet Silverado pickup truck. Tesla has a loyal customer base, but so does GM. Someone who's been a GM truck buyer for years is likely to stick with GM when they decide to switch to an electric vehicle.</p>\n<p><img src=\"https://static.tigerbbs.com/c651279799dfdf96552379a7b5d448a9\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>IMAGE SOURCE: GM.</p>\n<p><b>Ford</b>(NYSE:F)is also pouring resources into electric vehicles, allocating $29 billion for electric and autonomous vehicles through 2025. The company's plans include anelectric version of its F-150 pickup truck, which should hit the production lines by mid-2022. Given GM's and Ford's plans, it will not be easy for Tesla to steal away market share in the lucrative pickup-truck segment.</p>\n<p>Other car companies have big plans, as well.<b>Volkswagen</b>(OTC:VWAGY)already sells over 200,000 EVs annually andexpects that number to double this year. The company is aiming to sell roughly 2 million EVs annually by 2025 and expects to launch 70 EV models by 2030.<b>Toyota</b>(NYSE:TM)willlaunch 15 new electric vehicles by 2025, some of which will be under the new Toyota bZ sub-brand. The list goes on.</p>\n<p>Not only will all these electric vehicles provide consumers with a bevy of options beyond Tesla, but they'll also deprive Tesla of its regulatory-credit income as other automakers churn out an increasing number of EVs.</p>\n<p>None of this is to say that Tesla can't be successful in a world where it faces more competition. But turning a profit is is going to get harder with each passing year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>1 Question Tesla Investors Need to Ask Themselves</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n1 Question Tesla Investors Need to Ask Themselves\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 23:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/30/1-question-tesla-investors-need-to-ask-themselves/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Electric-car companyTesla(NASDAQ:TSLA)has now produced a profit for seven consecutive quarters. Tesla managed aGAAPnet income of $438 million in the first quarter, up from just $16 million one-year ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/30/1-question-tesla-investors-need-to-ask-themselves/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.fool.com/investing/2021/04/30/1-question-tesla-investors-need-to-ask-themselves/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146129324","content_text":"Electric-car companyTesla(NASDAQ:TSLA)has now produced a profit for seven consecutive quarters. Tesla managed aGAAPnet income of $438 million in the first quarter, up from just $16 million one-year prior. It would appear, at least at first glance, that the electric-vehicle (EV) pioneer is on the right track in terms of profitability.\nThe problem is that these profits aren't really coming from the cars that Tesla sells. The company currently generates hundreds of millions of dollars in pure profit each quarter from the sale of regulatory credits, a side effect of other automakers not making enough zero-emission vehicles to meet regulatory requirements.\nRegulatory credit sales totaled $518 million in the first quarter, accounting for all of Tesla's profit and then some. This has been the case in previous quarters, as well. In fact, after backing out regulatory credits from Tesla's net income, the company has been unprofitable for six-straight quarters.\nTesla's bottom line got an additional boost in the first quarter from a gain onthe sale ofBitcointo the tune of $101 million, which showed up as a reduction in costs. The picture doesn't look so rosy when both regulatory credits and Bitcoin gains are excluded:\n\nDATA SOURCE: TESLA. CHART BY AUTHOR.\nThere's no question that Tesla's growth is impressive, but there's also no question that the core business of making and selling cars is not turning a profit. The question Tesla investors need to ask themselves is: If Tesla isn't profitable now, when there's little to no competition in electric vehicles in the United States, what's going to happen when a deluge of competition fromtraditional automakersarrives?\nA ton of competition is coming\nTesla's brand has a cult following, so some people will be buying Tesla vehicles regardless of the other options available. But that's not likely to be the case for most people.\nThe number of electric vehicles available for purchase in the U.S. is set to explode in the coming years.General Motors(NYSE:GM)is planning to launch 30 EVs globally by 2025, with two-thirds set to be sold in North America. The company is aiming to sell 1 million EVs annually in North America by 2025.\nThose models include electric versions of the company's GMC Hummer and Chevrolet Silverado pickup truck. Tesla has a loyal customer base, but so does GM. Someone who's been a GM truck buyer for years is likely to stick with GM when they decide to switch to an electric vehicle.\n\nIMAGE SOURCE: GM.\nFord(NYSE:F)is also pouring resources into electric vehicles, allocating $29 billion for electric and autonomous vehicles through 2025. The company's plans include anelectric version of its F-150 pickup truck, which should hit the production lines by mid-2022. Given GM's and Ford's plans, it will not be easy for Tesla to steal away market share in the lucrative pickup-truck segment.\nOther car companies have big plans, as well.Volkswagen(OTC:VWAGY)already sells over 200,000 EVs annually andexpects that number to double this year. The company is aiming to sell roughly 2 million EVs annually by 2025 and expects to launch 70 EV models by 2030.Toyota(NYSE:TM)willlaunch 15 new electric vehicles by 2025, some of which will be under the new Toyota bZ sub-brand. The list goes on.\nNot only will all these electric vehicles provide consumers with a bevy of options beyond Tesla, but they'll also deprive Tesla of its regulatory-credit income as other automakers churn out an increasing number of EVs.\nNone of this is to say that Tesla can't be successful in a world where it faces more competition. But turning a profit is is going to get harder with each passing year.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":2529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106282534,"gmtCreate":1620124291528,"gmtModify":1704338958399,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580604694268529","idStr":"3580604694268529"},"themes":[],"htmlText":"Help comment and like please","listText":"Help comment and like please","text":"Help comment and like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/106282534","repostId":"1157490418","repostType":4,"repost":{"id":"1157490418","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620120727,"share":"https://ttm.financial/m/news/1157490418?lang=en_US&edition=fundamental","pubTime":"2021-05-04 17:32","market":"us","language":"en","title":"After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1157490418","media":"Tiger Newspress","summary":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares ","content":"<p style=\"text-align:left;\">(May 4)&nbsp;After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p>Shares of&nbsp;<b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><b>So what</b></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><b>Now what</b></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter surging nearly 24% yesterday, OCGN dipped 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-04 17:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p style=\"text-align:left;\">(May 4)&nbsp;After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p>Shares of&nbsp;<b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><b>So what</b></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><b>Now what</b></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157490418","content_text":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares of Ocugen(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.So whatResearchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"Now whatMusunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374918133,"gmtCreate":1619408364622,"gmtModify":1704723393855,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580604694268529","idStr":"3580604694268529"},"themes":[],"htmlText":"Lets all watch ocgn!! EUA","listText":"Lets all watch ocgn!! EUA","text":"Lets all watch ocgn!! EUA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/374918133","repostId":"1184404050","repostType":4,"isVote":1,"tweetType":1,"viewCount":1605,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":106282107,"gmtCreate":1620124242009,"gmtModify":1704338957739,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580604694268529","idStr":"3580604694268529"},"themes":[],"htmlText":"Hihi","listText":"Hihi","text":"Hihi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/106282107","repostId":"1157490418","repostType":4,"repost":{"id":"1157490418","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620120727,"share":"https://ttm.financial/m/news/1157490418?lang=en_US&edition=fundamental","pubTime":"2021-05-04 17:32","market":"us","language":"en","title":"After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1157490418","media":"Tiger Newspress","summary":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares ","content":"<p style=\"text-align:left;\">(May 4)&nbsp;After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p>Shares of&nbsp;<b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><b>So what</b></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><b>Now what</b></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter surging nearly 24% yesterday, OCGN dipped 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-04 17:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p style=\"text-align:left;\">(May 4)&nbsp;After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/231cd8867b2a322ce48be7afd711946c\" tg-width=\"633\" tg-height=\"479\" referrerpolicy=\"no-referrer\"><b>What happened</b></p><p>Shares of&nbsp;<b>Ocugen</b>(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.</p><p><b>So what</b></p><p>Researchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.</p><p>\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"</p><p><b>Now what</b></p><p>Musunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157490418","content_text":"(May 4) After surging nearly 24% yesterday, OCGN dipped 4% in premarket trading.What happenedShares of Ocugen(NASDAQ:OCGN)surged 23.8% on Monday after thebiotechnologycompany released promising data from a study of Covaxin, the COVID-19 vaccine candidate it hopes to bring to the U.S. market.So whatResearchers at the Indian Council of Medical Research (ICMR) - National Institute of Virology believe Covaxin could protect against multiple coronavirus strains. Covaxin appeared to be effective against a variant from Brazil known as B.1.128.2. A previous study indicated that Covaxin could also protect against variants from the U.K. and India.\"Covaxin continues to show strong results in all the studies conducted to date,\" Ocugen co-founder and CEO Dr. Shankar Musunuri said in a press release. \"We continue to believe this vaccine is a critical tool to include in our national arsenal to fight this pandemic.\"Now whatMusunuri said Ocugen submitted a comprehensive drug master file to the U.S. Food and Drug Administration (FDA). The company is also preparing its application for an Emergency Use Authorization. Ocugen's agreement with its drug development partner, India-based Bharat Biotech, gives it a 45% share of any profits from the sale of Covaxin in the U.S., should it gain regulatory authorization.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2346,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374911146,"gmtCreate":1619408313185,"gmtModify":1704723392398,"author":{"id":"3580604694268529","authorId":"3580604694268529","name":"WokeMan123","avatar":"https://community-static.tradeup.com/news/ed223a6e92173d05e8fd1ab8df1d9c16","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580604694268529","idStr":"3580604694268529"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/374911146","repostId":"2129296363","repostType":4,"repost":{"id":"2129296363","kind":"highlight","pubTimestamp":1619407680,"share":"https://ttm.financial/m/news/2129296363?lang=en_US&edition=fundamental","pubTime":"2021-04-26 11:28","market":"us","language":"en","title":"The psychology of a stock market bubble","url":"https://stock-news.laohu8.com/highlight/detail?id=2129296363","media":"MarketWatch","summary":"Worry about a bubble is widespread at the top of a bubbleSometimes people are drawn to investing bec","content":"<p>Worry about a bubble is widespread at the top of a bubble</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6aee1d89d41ff471a9548f988bd7c4fd\" tg-width=\"1260\" tg-height=\"840\" referrerpolicy=\"no-referrer\"><span>Sometimes people are drawn to investing because of 'gambler's excitement' Getty Images/iStockphoto</span></p><p>I have no idea whether the stock market is actually forming a bubble that's about to break.</p><p>But I do know that many bulls are fooling themselves when they think a bubble can't happen when so many of us are concerned about <a href=\"https://laohu8.com/S/AONE\">one</a>. In fact, <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the distinguishing characteristics of a bubble is that such concern is widespread.</p><p>This seems counterintuitive. You would think that a bubble is most vulnerable to forming and then popping when investors are oblivious to that possibility. But you would be wrong.</p><p>It's important for all of us to be aware of this bubble psychology, but especially if you're a retiree or a near-retiree. That's because, in that case, your investment horizon will be shorter than for those who are younger, and you therefore are less able to recover from the deflation of a market bubble.</p><p>To appreciate how widespread current concern about a bubble is, consider the accompanying chart of data from Google Trends. It plots the relative frequency of Google searches based on the term \"stock market bubble.\" Notice that this frequency has recently jumped to a far-higher level than at any other point over the last five years.</p><p><img src=\"https://static.tigerbbs.com/10c79372e12449d1f3e00acd1666c914\" tg-width=\"1260\" tg-height=\"849\" referrerpolicy=\"no-referrer\"></p><p>This widespread concern is entirely consistent with a bubble's formation, according to a definition proposed several decades ago by Robert Shiller, the Yale finance professor and Nobel laureate. According to him, a bubble is \"a market situation in which news of price increases spurs investor enthusiasm which spreads by psychological contagion from person to person, bringing in a larger and larger class of investors, who, despite doubts about fundamental value, are drawn to the investment partly through envy of others' successes and partly through a gambler's excitement.\" (I italicized the above phrase, not Shiller.)</p><p>Notice that recognition of overvaluation is an integral part of the definition.</p><p>This recognition was certainly present during the weeks and months prior to the popping of the Internet bubble in March 2000. During the early and middle years of the 1990s, you may recall, it was possible to justify higher prices while keeping a straight face. But that became less and less possible as prices continued going higher in the late 1990s, and especially as some dot-com companies went public with huge valuations despite having no assets, revenue or business plan.</p><p>Rather than responding by taking some chips off the table, however, many began freely admitting that a bubble was forming. They no longer tried to justify higher prices on fundamentals, but began justifying it instead in terms of the market's momentum. Prices should keep going up as FOMO seduces more and more investors to jump on the bandwagon.</p><p>There is no shortage of current analogies, of course. Take dogecoin, which was created as a joke and has no fundamental value. As a recent Wall Street Journal article outlined , the dogecoin \"serves no purpose and, unlike Bitcoin, faces no limit on the number of coins that exist.\" Yet investors are flocking to it, for no other apparent reason than it has already gone up so much. Billy Markus, the co-creator of dogecoin, was quoted in that Wall Street Journal article saying \"This is absurd. I haven't seen anything like it. It's one of those things that once it starts going up, it might keep going up.\"</p><p>Needless to say, things don't go up forever. Those who nevertheless continue to invest in such an environment do so with the implicit assumption that they will be able to recognize it, in advance, when the bubble is about to pop--and therefore able to leave the party before everyone else. This is a dangerous delusion, however; not everyone can be the first to leave the party.</p><p>The bottom line? Far from being a reason why a bubble isn't forming, the widespread current concern about a possible bubble is actually a reason to worry that it could be. Take heed.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The psychology of a stock market bubble</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe psychology of a stock market bubble\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-26 11:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/the-psychology-of-a-stock-market-bubble-11619198164?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Worry about a bubble is widespread at the top of a bubbleSometimes people are drawn to investing because of 'gambler's excitement' Getty Images/iStockphotoI have no idea whether the stock market is ...</p>\n\n<a href=\"https://www.marketwatch.com/story/the-psychology-of-a-stock-market-bubble-11619198164?mod=home-page\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/story/the-psychology-of-a-stock-market-bubble-11619198164?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2129296363","content_text":"Worry about a bubble is widespread at the top of a bubbleSometimes people are drawn to investing because of 'gambler's excitement' Getty Images/iStockphotoI have no idea whether the stock market is actually forming a bubble that's about to break.But I do know that many bulls are fooling themselves when they think a bubble can't happen when so many of us are concerned about one. In fact, one of the distinguishing characteristics of a bubble is that such concern is widespread.This seems counterintuitive. You would think that a bubble is most vulnerable to forming and then popping when investors are oblivious to that possibility. But you would be wrong.It's important for all of us to be aware of this bubble psychology, but especially if you're a retiree or a near-retiree. That's because, in that case, your investment horizon will be shorter than for those who are younger, and you therefore are less able to recover from the deflation of a market bubble.To appreciate how widespread current concern about a bubble is, consider the accompanying chart of data from Google Trends. It plots the relative frequency of Google searches based on the term \"stock market bubble.\" Notice that this frequency has recently jumped to a far-higher level than at any other point over the last five years.This widespread concern is entirely consistent with a bubble's formation, according to a definition proposed several decades ago by Robert Shiller, the Yale finance professor and Nobel laureate. According to him, a bubble is \"a market situation in which news of price increases spurs investor enthusiasm which spreads by psychological contagion from person to person, bringing in a larger and larger class of investors, who, despite doubts about fundamental value, are drawn to the investment partly through envy of others' successes and partly through a gambler's excitement.\" (I italicized the above phrase, not Shiller.)Notice that recognition of overvaluation is an integral part of the definition.This recognition was certainly present during the weeks and months prior to the popping of the Internet bubble in March 2000. During the early and middle years of the 1990s, you may recall, it was possible to justify higher prices while keeping a straight face. But that became less and less possible as prices continued going higher in the late 1990s, and especially as some dot-com companies went public with huge valuations despite having no assets, revenue or business plan.Rather than responding by taking some chips off the table, however, many began freely admitting that a bubble was forming. They no longer tried to justify higher prices on fundamentals, but began justifying it instead in terms of the market's momentum. Prices should keep going up as FOMO seduces more and more investors to jump on the bandwagon.There is no shortage of current analogies, of course. Take dogecoin, which was created as a joke and has no fundamental value. As a recent Wall Street Journal article outlined , the dogecoin \"serves no purpose and, unlike Bitcoin, faces no limit on the number of coins that exist.\" Yet investors are flocking to it, for no other apparent reason than it has already gone up so much. Billy Markus, the co-creator of dogecoin, was quoted in that Wall Street Journal article saying \"This is absurd. I haven't seen anything like it. It's one of those things that once it starts going up, it might keep going up.\"Needless to say, things don't go up forever. Those who nevertheless continue to invest in such an environment do so with the implicit assumption that they will be able to recognize it, in advance, when the bubble is about to pop--and therefore able to leave the party before everyone else. This is a dangerous delusion, however; not everyone can be the first to leave the party.The bottom line? Far from being a reason why a bubble isn't forming, the widespread current concern about a possible bubble is actually a reason to worry that it could be. Take heed.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":1913,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}